LEO Pharma’s new R&D lead on driving agility in drug development

After 27 years at Bayer, Jörg Möller has moved to LEO Pharma as the company’s EVP, global research and development. We spoke to him about the lessons he’s taking from his prior jobs into the new role and what it means to be an R&D leader in the modern industry.